{"id":"placebo-device-nasacort","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nasal congestion"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by inhibiting the release of inflammatory mediators from mast cells and other cells in the nasal mucosa, leading to a decrease in symptoms of allergic rhinitis.","oneSentence":"Nasacort is a corticosteroid that works by reducing inflammation in the nasal passages.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:55.304Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal allergic rhinitis"},{"name":"Perennial allergic rhinitis"}]},"trialDetails":[{"nctId":"NCT06004882","phase":"NA","title":"Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-08-10","conditions":"Peripheral Nerve Stimulation, Genicular Nerves, Chronic Knee Pain","enrollment":45},{"nctId":"NCT00444600","phase":"PHASE3","title":"Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2007-03","conditions":"Diabetic Retinopathy, Diabetic Macular Edema","enrollment":691},{"nctId":"NCT00665977","phase":"PHASE3","title":"Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure","status":"COMPLETED","sponsor":"Clayton Sleep Insititute","startDate":"2007-09","conditions":"Obstructive Sleep Apnea, Nasal Congestion, Sinus Congestion","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo Device & Nasacort","genericName":"Placebo Device & Nasacort","companyName":"Clayton Sleep Insititute","companyId":"clayton-sleep-insititute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nasacort is a corticosteroid that works by reducing inflammation in the nasal passages. Used for Seasonal allergic rhinitis, Perennial allergic rhinitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}